Ep. 107: Digital Trust Ecosystem - PharmaLedger (Dan Fritz & Marco Cuomo)

In today's episode, host Ray Dogum sits down with guests Dan Fritz and Marco Cuomo. Marco is an Applied Technology Innovation Manager with a passion for exploring and implementing new technologies such as blockchain and API Management. Dan is a Supply Chain Domain Architect at Novartis, where he is responsible for the architecture vision and selection of emerging technologies that will transform the business. Tune in to hear the trio discuss how blockchain will transform healthcare by driving patient safety, reliable product traceability, and aiding the fight against counterfeiting. In the News Corner, Ray shares why crypto companies sponsoring major sporting events is not a good enough reason for investors to trust them.  Topics Covered Include: 01:00 Introduction 03:16 PharmaLedger Leaders Discuss The Transition From PharmaLedger Consortium to PharmaLedger Association 08:21 Partners Unite To Accelerate Medical Innovation In Health Care 10:07 Industry Consortium Kicks Off Project After Two Years Of Planning 11:34 Creating a Digital Trust Ecosystem In the Healthcare Industry 13:35 Blockchain Technology Enables Win-win Solutions For Partners In Digital Trust Ecosystems 14:55 Building An Infrastructure For The Healthcare Industry: A Step Towards A Unified Blockchain Network 17:56 Testing The Flexibility Of Electronic Product Information: Switching From Ethereum To Hyperledger 22:05 Pandemic Accelerates Digital Transformation With Self Sovereign Identity Solutions 25:25 Clinical Trial Investigators Streamline Supply Chain Process For Business Benefits 27:39 Blockchain Revolutionizes Pharmaceutical Supply Chain To Combat Counterfeiting 29:59 Creating Value For Members And Users: Experiences From Test Pilots And User Research through electronic product information 34:34 Technology Ready For Implementation In Healthcare, But Regulatory Checks Remain 38:10 Ensuring Privacy: Is Your Medical Data Safe? 39:33 Four Nodes Required For Go Quorum Consensus Protocol 40:56 Pharma Companies Establish Trust Through Hybrid Blockch